Skip to main content
SpringerLink
Log in

Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity

  • Original Paper
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

We have examined the expression of 72-kDa gelatinase/type IV collagenase or matrix metalloproteinase-2 (MMP-2) and ist inhibitor, tissue inhibitor of metalloproteinase-2 (TIMP-2), in various cell lines derived from paediatric tumours. In a neuroblastoma model system of tumour progression, the expression level of MMP-2 mRNA was higher in the more malignant cell line. Surprisingly, MMP-2 was not expressed in the highly malignant rhabdomyosarcoma A-204 cell line. TIMP-2 showed higher expression levels in the 007 and U-2OS tumour cell lines than in the more malignant ones, WAC2 and A-204 cells. We have also determined the effect of some tumour cell proliferation modulators on gelatinolytic activity. While basic fibroblast growth factor and retinoic acid produced no apparent change in gelatinolytic activity, genistein induced in partial inhibition of gelatinolytic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

MMP :

matrix metalloproteinase

TIMP :

tissue inhibitor of metalloproteinases

bFGF :

basic fibroblast growth factor

GAPDH :

glyceraldehyde-3-phosphate dehydrogenase

ECM :

extracellular matrix

References

  • Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fuami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592–5595

    PubMed  Google Scholar 

  • Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Río MC, Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699–704

    PubMed  Google Scholar 

  • Briozzo P, Morisset M, Capony F, Rougeot G, Rochefort H (1988) In vitro degradation of extracellular matrix withM r 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 48: 3688–3692

    PubMed  Google Scholar 

  • Burgess WH, Maciag T (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58: 575–606

    PubMed  Google Scholar 

  • Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159

    PubMed  Google Scholar 

  • Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA, Goldberg C (1988) H-ras oncogene transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263: 6579–6587

    PubMed  Google Scholar 

  • Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 45: 139–266

    Google Scholar 

  • Favennec L, Cals MJ (1988) The biological effect of retinoids on cell differentiation and proliferation. J Clin Chem Clin Biochem 26: 479–489

    PubMed  Google Scholar 

  • Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931–10934

    PubMed  Google Scholar 

  • Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993) Genistein, a novel dietary-derived angiogensis inhibitor. Proc Natl Acad Sci USA 90: 2690–2694

    PubMed  Google Scholar 

  • Gottesman M (1990) The role of proteases in cancer. Semin Cancer Biol 1: 97–160

    Google Scholar 

  • Kao RT, Wong M, Stern R (1982) Elastin degradation by proteinases from cultured human breast cancer cells. Biochem Biophys Res Commun 105: 383–389

    PubMed  Google Scholar 

  • Liotta LA, Tryggvason K, Garbisa S, Hart IR, Foltz CM, Shaflie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67–69

    PubMed  Google Scholar 

  • Liotta LA, Rao CN, Barsky SH (1983) Tumor invasion and the extracellular matrix. Lab Invest 49: 636–649

    PubMed  Google Scholar 

  • Liotta LA, Steeg PS, Steller-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336

    PubMed  Google Scholar 

  • Medina MA, Del Castillo-Olivares A, Schweigerer L (1992) Plasma membrane redox activity correlates with N-myc expression in neuroblastoma cells. FEBS Lett 311: 99–101

    PubMed  Google Scholar 

  • Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M (1990) Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res 50: 7758–7764

    PubMed  Google Scholar 

  • Murphy G, Cawston T, Reynolds J (1981) An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J 195: 167–170

    PubMed  Google Scholar 

  • Nakajima M, Welch D, Belloni PN, Nicolson GL (1987) Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 4869–4876

    PubMed  Google Scholar 

  • Okada Y, Gonoki Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T (1992) Matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem 267:21712–21719

    PubMed  Google Scholar 

  • Poole AR, Tiltman KJ, Recklies AD, Stocker TAM (1990) Differences in secretion of the proteinase cathepsine B at the edge of human breast carcinomas and fibrosarcomas. Nature 273: 545–549

    Google Scholar 

  • Salo T, Liotta LA, Tryggvason K (1983) Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. J Biol Chem 258: 3058–3063

    PubMed  Google Scholar 

  • Samuel SK, Hurta RAR, Kondaiah P, Khalil N, Turley EA, Wright JA, Greenberg AH (1992) Autocrine induction of tumor protease production and invasion by a metallothioniein-regulated TGF-β1 (Ser223,225). EMBO J 11: 1599–1605

    PubMed  Google Scholar 

  • Sappino AP, Busso N, Belin D, Vassali JD (1987) Increase of urokinase type plasminogen activator gene expression in human lung and breast carcinoma. Cancer Res 47: 4043–4046

    PubMed  Google Scholar 

  • Schwab M (1990) Amplification of the gene MYCN in human neuroblastoma. Crit Rev Oncogenesis 2: 35–51

    PubMed  Google Scholar 

  • Schweigerer L, Neufeld G, Gospodarowicz D (1987) Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J Clin Invest 80: 1516–1520

    PubMed  Google Scholar 

  • Schweigerer L, Breit S, Wenzel A, Tsunamoto K, Ludwig R, Schwab M (1990) Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity. Cancer Res 50: 4411–4416

    PubMed  Google Scholar 

  • Schweigerer L, Christeleit K, Fleischmann G, Adlercreutz H, Wähälä K, Hase T, Schwab M, Ludwig R, Fotsis T (1992) Identification in human urine of a natural growth inhibitor for cells derived from solid pediatric tumors. Eur J Clin Invest 22: 260–264

    PubMed  Google Scholar 

  • Stetler-Stevenson WG, Krutsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). J Biol Chem 264: 17374–17378

    PubMed  Google Scholar 

  • Troen BR, Ascherman D, Atlas D, Gottesman MM (1988) Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation. J Biol Chem 263: 254–261

    PubMed  Google Scholar 

  • Turpeeniemi-Hujanen T, Thorgeirsson UP, Hartl IR, Grant S, Liotta LA (1985) Expresiion of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J Natl Cancer Inst 75: 99–108

    PubMed  Google Scholar 

  • Urdiales JL, Matés JM, Núñez de Castro I, Sánchez-Jiménez FM (1992) Chlorpheniramine inhibits the ornithine decarboxilase induction of Ehrlich carcinoma growing in vivo. FEBS Lett 305: 260–264

    PubMed  Google Scholar 

  • Welgus HG, Jeffrey JJ, Eisen AZ (1981) The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem 256: 9511–9515

    PubMed  Google Scholar 

  • Yang TT, Hawkes SP (1992) Role of the 21 kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci USA 89: 10676–10680

    PubMed  Google Scholar 

  • Zheng ZS, Polakowska R, Johnson A, Goldsmith LA (1992) Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth Differ 3: 225–232

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratorio de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Málaga, E-29071, Málaga, Spain

    Rocío Garcia de Veas & Miguel Angel Medina

  2. Division of Hematology/Oncology, Children's University Hospital, INF 150, D-69120, Heidelberg, Germany

    Lothar Schweigerer & Miguel Angel Medina

Authors
  1. Rocío Garcia de Veas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lothar Schweigerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miguel Angel Medina
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Veas, R.G., Schweigerer, L. & Medina, M.A. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity. J Cancer Res Clin Oncol 121, 275–278 (1995). https://doi.org/10.1007/BF01209593

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01209593

Key Words

Search

Navigation